Antimicrobial Agents Practice Questions

Q: Which of the following anti-tuberculosis drugs should not be given to an AIDS patient?

Rifampicin. ### Explanation The correct answer is **Rifampicin**. **Why Rifampicin is avoided in certain AIDS patients:** The primary concern in treating a patient with both HIV and Tuberculosis (TB) is **drug-drug interactions**. Rifampicin is a **potent inducer of the Cytochrome P450 (CYP3A4) enzyme system**. Most Protease Inhibitors (PIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), which are cornerstones of Highly Active Antiretroviral Therapy (HAART), are metabolized by this same enzyme system. When Rifampicin is administered, it significantly accelerates the metabolism of these antiretroviral drugs, leading to sub-therapeutic plasma levels, treatment failure, and the development of drug resistance. In clinical practice, **Rifabutin** is often used as a substitute because it is a much weaker enzyme inducer. **Why the other options are incorrect:** * **Ethambutol:** It does not interfere with the CYP450 system and has no significant interactions with HAART. Its main side effect is optic neuritis. * **Streptomycin:** An aminoglycoside that is excreted renally. It does not interact with the hepatic metabolism of antiretroviral drugs. * **Pyrazinamide:** It is a key component of the short-course intensive phase and does not have major metabolic interactions with HIV medications. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** If a patient is on a PI-based regimen, **Rifabutin** is preferred over Rifampicin. * **Efavirenz Exception:** Rifampicin can be used if the patient is on an **Efavirenz-based** regimen (though the dose of Efavirenz may need adjustment). * **IRIS:** Be alert for **Immune Reconstitution Inflammatory Syndrome**, which occurs when the immune system recovers and reacts aggressively to the TB bacilli. * **Mnemonic:** Rifampicin **"Ramps up"** enzymes (Inducer); Cimetidine/Ketoconazole **"Cuts down"** enzymes (Inhibitors).

Q: What is the primary treatment for Clostridioides difficile infection?

All of the above. The primary treatment for Clostridioides difficile infection (CDI) involves antibiotics that are effective against anaerobic gram-positive bacilli and reach therapeutic concentrations in the colon. While clinical guidelines have evolved, all the listed drugs possess activity against C. difficile. * **Metronidazole (Option A):** Historically the first-line drug for mild-to-moderate CDI [1]. It is a nitroimidazole that disrupts DNA synthesis in anaerobes. Although current IDSA guidelines favor Vancomycin or Fidaxomicin, Metronidazole remains a valid primary treatment option, especially in resource-limited settings [2]. * **Bacitracin (Option B):** Though less commonly used today due to the availability of more potent agents, oral Bacitracin is poorly absorbed from the gut, allowing it to reach high intraluminal concentrations. It inhibits cell wall synthesis and is an FDA-approved alternative for CDI. * **Nitazoxanide (Option C):** Primarily an antiprotozoal, this agent also has significant activity against C. difficile. It is often used as an alternative primary treatment or in cases of refractory infection. **Why "All of the above" is correct:** All three medications are recognized pharmacological interventions for the primary management of CDI, depending on the severity and clinical context. **NEET-PG High-Yield Pearls:** * **Drug of Choice (Current):** Oral **Vancomycin** or **Fidaxomicin** are now preferred over Metronidazole for the first episode of CDI [2]. * **Fidaxomicin:** A macrocyclic antibiotic that inhibits RNA polymerase; it has a narrower spectrum and lower recurrence rates compared to Vancomycin. * **Route of Administration:** For CDI, Vancomycin must be given **orally** (not IV) to ensure it reaches the site of infection in the colon. * **Severe/Fulminant CDI:** Treated with a combination of high-dose oral Vancomycin and IV Metronidazole.

Q: Which of the following is NOT a first-generation cephalosporin?

Cefaclor. **Explanation:** Cephalosporins are classified into "generations" based on their spectrum of activity and chronological development. **Why Cefaclor is the correct answer:** **Cefaclor** is a **second-generation cephalosporin**. Unlike first-generation agents, second-generation cephalosporins have an extended spectrum that includes better coverage against Gram-negative organisms (such as *H. influenzae*, *Enterobacter*, and *Neisseria* spp.) while retaining some Gram-positive activity. **Analysis of incorrect options (First-generation agents):** First-generation cephalosporins are highly active against Gram-positive cocci (Streptococci, Staphylococci) but have a limited Gram-negative spectrum (PEcK: *Proteus, E. coli, Klebsiella*). * **Cefadroxil (Option A):** An oral first-generation agent commonly used for skin and soft tissue infections. * **Cefazolin (Option B):** A parenteral first-generation agent. It is the drug of choice for **surgical prophylaxis** due to its long half-life and activity against *S. aureus*. * **Cephalexin (Option C):** A widely used oral first-generation agent, often prescribed for uncomplicated UTIs and minor skin infections. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mnemonic for 1st Gen:** "Ph/f" sound (Ce**ph**alexin, Ce**ph**alothin, Ce**f**azolin, Ce**f**adroxil). *Exception: Cefaclor (2nd gen).* 2. **Mnemonic for 2nd Gen:** "FAM, FUR, FOX, FAC" (Ce**fam**andole, Ce**fur**oxime, Ce**fox**itin, Ce**fac**lor). 3. **Cefazolin** is unique because it does not penetrate the CNS; hence, it is never used for meningitis. 4. **Cefaclor** is specifically associated with a **serum sickness-like reaction** in children.

Q: Which of the following drugs is NOT used in the treatment of herpes simplex encephalitis?

Amantadine. ### Explanation **Correct Option: D. Amantadine** **Why Amantadine is the correct answer:** Amantadine is an anti-influenza agent, not an anti-herpetic drug. Its mechanism of action involves inhibiting the **M2 ion channel** of the Influenza A virus, which prevents viral uncoating. It has no activity against DNA viruses like Herpes Simplex Virus (HSV). Clinically, amantadine is more commonly used today in Parkinson’s disease (due to its NMDA antagonism and dopamine-releasing effects) rather than as an antiviral. **Why the other options are incorrect:** * **A. Acyclovir:** This is the **drug of choice** for Herpes Simplex Encephalitis (HSE). It is a guanosine analog that requires phosphorylation by viral **thymidine kinase** to become active, leading to DNA chain termination. * **B. Vidarabine:** Historically, vidarabine was used to treat HSE before acyclovir was developed. While effective, it is rarely used now due to its significant toxicity and the superior safety profile of acyclovir. * **C. Ganciclovir:** Although primarily used for Cytomegalovirus (CMV) infections, ganciclovir does possess significant activity against HSV-1 and HSV-2. In cases of acyclovir resistance, it may be considered, though it is not the first-line agent for HSE. **High-Yield Clinical Pearls for NEET-PG:** * **HSE Presentation:** Typically involves the **temporal lobes**, leading to seizures, personality changes, and aphasia. * **Drug of Choice:** Intravenous (IV) Acyclovir (10 mg/kg every 8 hours for 14–21 days). * **Acyclovir Resistance:** Usually occurs due to a mutation in the viral **thymidine kinase** enzyme. The drug of choice for acyclovir-resistant HSV is **Foscarnet**. * **Amantadine Side Effect:** Look for **Livedo Reticularis** (a lace-like purplish skin discoloration) in exam questions.

Q: Which of the following is true regarding Carbenicillin?

Is effective in Pseudomonas infections.. **Explanation:** Carbenicillin is a semi-synthetic penicillin belonging to the **Extended-spectrum Penicillins** (specifically the Carboxypenicillin group). **1. Why Option A is Correct:** Carbenicillin was the first penicillin developed with specific activity against *Pseudomonas aeruginosa*. It works by inhibiting bacterial cell wall synthesis. While newer agents like Piperacillin (Ureidopenicillins) are now more potent, Carbenicillin remains a prototype for anti-pseudomonal activity. **2. Why the other options are Incorrect:** * **Option B:** Carbenicillin is highly effective against indole-positive *Proteus* species. In fact, its spectrum includes many Gram-negative organisms that are resistant to Ampicillin. * **Option C:** Carbenicillin is a **Beta-lactam antibiotic** (Penicillin group), not a macrolide. Macrolides (like Erythromycin) inhibit protein synthesis by binding to the 50S ribosomal subunit. * **Option D:** Carbenicillin is **acid-labile** and poorly absorbed from the gut. Therefore, it must be administered parenterally (IV/IM). An oral prodrug, Carbenicillin indanyl, exists but is only used for urinary tract infections due to low systemic levels. **High-Yield Clinical Pearls for NEET-PG:** * **Sodium Load:** Carbenicillin is administered as a disodium salt. High doses can lead to **hypernatremia** and fluid retention, which is critical in patients with heart failure or renal insufficiency. * **Platelet Dysfunction:** It can cause bleeding by interfering with platelet aggregation (not by causing thrombocytopenia). * **Synergy:** It is often used in combination with Aminoglycosides (like Gentamicin) for synergistic effects against *Pseudomonas*, but they should never be mixed in the same IV bottle as they chemically inactivate each other.

Q: Which of the following anti-tubercular drugs can cause hypothyroidism?

Para-aminosalicylic acid (PAS). **Explanation:** **Para-aminosalicylic acid (PAS)** is the correct answer because it acts as a potent **goitrogen**. It interferes with the synthesis of thyroid hormones by inhibiting the enzyme **iodide peroxidase**, which is essential for the organification of iodine. Prolonged use of PAS, especially in multidrug-resistant TB (MDR-TB) regimens, can lead to compensatory thyroid gland enlargement (goiter) and clinical hypothyroidism. This effect is reversible upon discontinuation of the drug or can be managed with levothyroxine supplementation during treatment. **Analysis of Incorrect Options:** * **Ethionamide:** While Ethionamide is structurally related to Thioamides (like PTU) and can occasionally cause hypothyroidism, **PAS is the classic and more frequently tested culprit** in pharmacology exams for this specific side effect. * **Cycloserine:** This is a second-line agent primarily known for its **neuropsychiatric side effects**, including psychosis, seizures, and depression (“Psych-oserine”). It has no significant effect on thyroid function. * **Pyrazinamide:** A first-line agent (part of RIPE) known for causing **hyperuricemia** (leading to gout) and hepatotoxicity [1]. It does not cause hypothyroidism. **NEET-PG Clinical Pearls:** * **PAS Side Effects:** GI distress (most common), hypothyroidism, and hypersensitivity reactions. * **Drug of Choice for Hypothyroidism:** Levothyroxine (T4). * **MDR-TB Monitoring:** Patients on both PAS and Ethionamide require regular TSH monitoring as the risk of hypothyroidism is additive when these two drugs are used together. * **High-Yield Fact:** PAS is primarily used for MDR-TB and is bacteriostatic, acting by inhibiting folic acid synthesis (similar to sulfonamides).

Q: Which drug is used for antibiotic-associated pseudomembranous enterocolitis and is also part of the anti-Helicobacter pylori treatment regimen?

Metronidazole. ### Explanation **Correct Answer: C. Metronidazole** **Mechanism and Rationale:** Metronidazole is a nitroimidazole derivative that acts against anaerobic bacteria and protozoa. It is a key drug in the management of **Pseudomembranous Enterocolitis** (caused by *Clostridioides difficile*), particularly for mild-to-moderate cases [1]. While oral Vancomycin is often preferred for severe cases, Metronidazole remains a classic therapeutic option. Additionally, Metronidazole is a core component of the **H. pylori eradication regimens** (such as the Bismuth-based quadruple therapy or as a substitute for Amoxicillin in triple therapy for penicillin-allergic patients) [1]. It works by forming reactive cytotoxic intermediates that damage bacterial DNA. **Analysis of Incorrect Options:** * **A. Amoxicillin:** While used in the *H. pylori* triple therapy regimen, it is **not** used to treat pseudomembranous enterocolitis. In fact, broad-spectrum penicillins like Amoxicillin are common *causes* of antibiotic-associated diarrhea. * **B. Vancomycin:** This is a first-line treatment for *C. difficile* (given orally), but it has **no role** in the treatment of *H. pylori*. * **D. Clotrimazole:** This is an antifungal agent (imidazole) used for candidiasis and tinea infections; it has no antibacterial activity against *C. difficile* or *H. pylori*. **High-Yield NEET-PG Pearls:** * **Disulfiram-like reaction:** Patients taking Metronidazole must avoid alcohol due to inhibition of aldehyde dehydrogenase. * **Drug of Choice:** Metronidazole is the DOC for **Amoebiasis, Giardiasis, Trichomoniasis,** and **Anaerobic infections** (below the diaphragm). * **Side Effect:** A common side effect is a **metallic taste** in the mouth. * **H. pylori Triple Therapy:** Includes a PPI + Clarithromycin + Amoxicillin (or Metronidazole).

Q: A drug exhibits activity against many strains of P. aeruginosa. However, resistance emerges during treatment when used alone. This drug should not be administered to penicillin-allergic patients. Its activity against gram-negative rods is enhanced when given in combination with tazobactam. Which of the following drugs is being described?

Piperacillin. The drug described is **Piperacillin**, an extended-spectrum antipseudomonal penicillin.1. Why Piperacillin is correct: * **Spectrum:** Piperacillin is highly effective against *Pseudomonas aeruginosa*. * **Resistance:** When used as monotherapy, bacteria can rapidly develop resistance via the production of beta-lactamases. To prevent this and broaden its spectrum, it is almost always combined with **Tazobactam** (a beta-lactamase inhibitor) [1]. * **Cross-reactivity:** As a member of the penicillin family, it shares the 6-aminopenicillanic acid nucleus. Therefore, it is contraindicated in patients with a history of severe penicillin allergy due to the risk of anaphylaxis [1].2. Why the other options are incorrect: * **Amoxicillin (A):** While a penicillin, it has **no activity** against *Pseudomonas*. It is primarily used for gram-positive and select gram-negative organisms (e.g., *H. influenzae*). * **Aztreonam (B):** This is a monobactam. Crucially, it has **no cross-reactivity** with penicillins (except ceftazidime) and is the drug of choice for treating gram-negative infections in penicillin-allergic patients [2]. * **Vancomycin (D):** This is a glycopeptide that acts only on **gram-positive** bacteria (e.g., MRSA). It has no activity against gram-negative rods like *Pseudomonas*.High-Yield Clinical Pearls for NEET-PG: * **Antipseudomonal Penicillins:** Include Carboxypenicillins (Ticarcillin) and Ureidopenicillins (Piperacillin). Piperacillin is the most potent. * **The "Safe" Beta-lactam:** Aztreonam is the only beta-lactam that can be safely given to a patient with a documented Type-1 hypersensitivity to penicillin. * **Synergy:** Antipseudomonal penicillins are often combined with Aminoglycosides for synergistic effects, but they should never be mixed in the same IV bottle as they can chemically inactivate each other.

Q: A patient is administered intravenous quinine and subsequently develops restlessness and sweating. What is the most likely cause?

Hypoglycemia. **Explanation:** **1. Why Hypoglycemia is the correct answer:** Quinine is a potent stimulator of the **pancreatic beta cells**, leading to the hypersecretion of insulin (hyperinsulinemia). This often results in profound **fasting hypoglycemia**. In clinical practice, symptoms like restlessness, sweating, palpitations, and confusion in a patient receiving IV quinine are classic indicators of a drop in blood glucose levels. This is particularly common in pregnant patients or those with severe malaria. **2. Analysis of Incorrect Options:** * **B. Cinchonism:** This is a dose-related toxicity of quinine characterized by tinnitus, high-frequency hearing loss, dizziness, headache, and visual disturbances. While common, it does not typically present with acute sweating and restlessness as the primary symptoms. * **C. Arrhythmias:** Quinine has class 1A anti-arrhythmic properties and can cause QT prolongation. While life-threatening, it usually presents with syncope or palpitations rather than the autonomic "sympathetic overactivity" (sweating/restlessness) seen in hypoglycemia. * **D. Sweating:** This is a symptom, not the underlying "cause" or diagnosis requested by the question. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice:** Quinine was historically the drug of choice for cerebral malaria, but **Artesunate** (IV) is now preferred due to better efficacy and fewer side effects. * **Blackwater Fever:** A rare but serious complication of quinine therapy involving massive intravascular hemolysis and hemoglobinuria. * **Safe in Pregnancy:** Quinine is considered safe for treating malaria in the first trimester of pregnancy. * **Management:** Always monitor blood glucose levels when administering IV quinine; if hypoglycemia occurs, it is managed with IV dextrose.

Question 1

Which of the following anti-tuberculosis drugs should not be given to an AIDS patient?

Accepted Answer

Rifampicin

Answer

Ethambutol

Answer

Streptomycin

Answer

Pyrazinamide

Question 2

What is the primary treatment for Clostridioides difficile infection?

Accepted Answer

All of the above

Answer

Metronidazole

Answer

Bacitracin

Answer

Nitazoxanilide

Question 3

Which of the following is NOT a first-generation cephalosporin?

Accepted Answer

Cefaclor

Answer

Cefadroxil

Answer

Cefazolin

Answer

Cephalexin

Question 4

Which of the following drugs is NOT used in the treatment of herpes simplex encephalitis?

Accepted Answer

Amantadine

Answer

Acyclovir

Answer

Vidarabine

Answer

Ganciclovir

Question 5

Which of the following is true regarding Carbenicillin?

Accepted Answer

Is effective in Pseudomonas infections.

Answer

Has no effect in Proteus infections.

Answer

Is a macrolide antibiotic.

Answer

Is administered orally.

Question 6

Which of the following anti-tubercular drugs can cause hypothyroidism?

Accepted Answer

Para-aminosalicylic acid (PAS)

Answer

Ethionamide

Answer

Cycloserine

Answer

Pyrazinamide

Question 7

Which drug is used for antibiotic-associated pseudomembranous enterocolitis and is also part of the anti-Helicobacter pylori treatment regimen?

Accepted Answer

Metronidazole

Answer

Amoxicillin

Answer

Vancomycin

Answer

Clotrimazole

Question 8

A drug exhibits activity against many strains of P. aeruginosa. However, resistance emerges during treatment when used alone. This drug should not be administered to penicillin-allergic patients. Its activity against gram-negative rods is enhanced when given in combination with tazobactam. Which of the following drugs is being described?

Accepted Answer

Piperacillin

Answer

Amoxicillin

Answer

Aztreonam

Answer

Vancomycin

Question 9

A patient is administered intravenous quinine and subsequently develops restlessness and sweating. What is the most likely cause?

Accepted Answer

Hypoglycemia

Answer

Cinchonism

Answer

Arrhythmias

Answer

Sweating

Question 10

Which antimalarial drug is known to cause neuropsychiatric adverse reactions?

Accepted Answer

Mefloquine

Answer

Artesunate

Answer

Artemisinin

Answer

Quinine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?